Animal models of cardiac cachexia.

Area of Science:

• Biomedical research
• Cardiology
• Physiology

Background:

• Cachexia is characterized by significant weight loss, primarily skeletal muscle and adipose tissue depletion, often accompanying chronic diseases like chronic heart failure (CHF).
• Existing in vivo cachexia research predominantly uses cancer cachexia models, leaving a gap in reliable models for cardiac cachexia.
• Developing cardiac cachexia models is challenging, as interventions for heart failure may inadvertently affect skeletal muscle due to shared physiological mechanisms.

Purpose of the Study:

• To describe the key features of cardiac cachexia.
• To review and illustrate existing animal models proposed for studying cardiac cachexia.
• To emphasize the critical need for specific cardiac cachexia models to unravel disease peculiarities and identify therapeutic targets.

Main Methods:

• Review of existing literature on cardiac cachexia and animal models.
• Description of genetic models: calsequestrin and Dahl salt-sensitive.
• Illustration of pharmacological and surgical models: monocrotaline, left anterior descending (LAD) ligation, transverse aortic constriction (TAC), and ascending aortic banding.

Main Results:

• Cardiac cachexia involves skeletal muscle wasting and fat depletion in the context of heart failure.
• Several animal models exist, including genetic, pharmacological, and surgical approaches.
• No single model perfectly replicates all aspects of cardiac cachexia, and some models do not consistently induce skeletal muscle loss.

Conclusions:

• Establishing specific and reliable animal models for cardiac cachexia is crucial for advancing research.
• Understanding the unique pathological features of cardiac cachexia is essential for developing targeted therapies.
• Further research into these models will aid in identifying novel therapeutic strategies for cachexia in chronic heart failure.